Diebold Nixdorf (DBD) Stock Overview
Engages in the automating, digitizing, and transforming the way people bank and shop worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
DBD Community Fair Values
See what 17 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Diebold Nixdorf, Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$66.48 |
| 52 Week High | US$92.09 |
| 52 Week Low | US$54.48 |
| Beta | 1.14 |
| 1 Month Change | -7.23% |
| 3 Month Change | -18.56% |
| 1 Year Change | 11.62% |
| 3 Year Change | 270.16% |
| 5 Year Change | n/a |
| Change since IPO | 223.19% |
Recent News & Updates
Diebold Nixdorf: Nothing That Turns The Eye
Summary Diebold Nixdorf is rated a "Hold" despite a 42.86% 12-month rally, driven by strong Retail segment performance and management's robust FY2026 free cash flow guidance. DBD trades at a discounted P/FCF versus the sector median, but Banking segment growth remains lackluster, limiting upside until automated/teller cash recycler sales accelerate. Retail segment momentum is underpinned by self-checkout technology and Smart Vision, addressing shrink and labor costs, with backlog rising to $790 million. Recent restructuring reduced legacy debt, but high-interest costs (9.9%) and modest 6% YoY consolidated revenue growth temper enthusiasm for a higher rating. Read the full article on Seeking AlphaDBD: Index Reclassification And Buybacks Will Support Future Earnings Power
Analysts have raised their price target on Diebold Nixdorf from $77.00 to $95.00, citing updated assumptions for the discount rate, revenue growth, profit margin, and a higher future P/E multiple. What's in the News Diebold Nixdorf was dropped from several Russell value-oriented benchmarks, including the Russell 2000 Value, Russell 3000E Value, Russell Small Cap Comp Value, and Russell 2500 Value indexes (source: index constituent changes).DBD: ATM Service Wins And Earnings Momentum Will Support Bullish Re Rating
Analysts kept their $100.00 price target on Diebold Nixdorf unchanged, pointing to only modest tweaks in discount rate, revenue growth, profit margin, and future P/E assumptions that did not materially alter their valuation view. What’s in the News for Diebold Nixdorf Diebold Nixdorf reported Q1 2026 results with revenue 6.03% higher year over year and net profit up about 2.6x, which supported higher analyst forecasts for current quarter earnings per share.Recent updates
Shareholder Returns
| DBD | US Tech | US Market | |
|---|---|---|---|
| 7D | -1.7% | -1.1% | 0.9% |
| 1Y | 11.6% | 49.0% | 15.5% |
Return vs Industry: DBD underperformed the US Tech industry which returned 49% over the past year.
Return vs Market: DBD underperformed the US Market which returned 15.5% over the past year.
Price Volatility
| DBD volatility | |
|---|---|
| DBD Average Weekly Movement | 6.6% |
| Tech Industry Average Movement | 11.7% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DBD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DBD's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1859 | 20,000 | Octavio Marquez | www.dieboldnixdorf.com |
Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers automated teller machines, cash recyclers, dispensers, teller automation tools, and kiosk technologies.
Diebold Nixdorf, Incorporated Fundamentals Summary
| DBD fundamental statistics | |
|---|---|
| Market cap | US$2.28b |
| Earnings (TTM) | US$111.20m |
| Revenue (TTM) | US$3.87b |
Is DBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DBD income statement (TTM) | |
|---|---|
| Revenue | US$3.87b |
| Cost of Revenue | US$2.85b |
| Gross Profit | US$1.02b |
| Other Expenses | US$906.10m |
| Earnings | US$111.20m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.28 |
| Gross Margin | 26.27% |
| Net Profit Margin | 2.87% |
| Debt/Equity Ratio | 94.3% |
How did DBD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/09 22:09 |
| End of Day Share Price | 2026/09/09 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Diebold Nixdorf, Incorporated is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Reik Read | Baird |
| Justin Ages | CJS Securities, Inc. |